OSUR
What one share of Orasure Technologies holds
Surgical and Medical Instruments and Apparatus
Our products and services reside under one reporting hierarchy, with commercial and innovation teams, which are part of a single business unit covering multiple product lines. Our business is principally comprised of the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions.
Orasure Technologies’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.59 |
|---|---|
| Profit | −$0.69 |
| Capex (buildings and equipment) | $0.07 |
| Free cash flow | −$0.68 |
| Cash and investments | $2.33 |
| Book value | $4.61 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.27 | $0.35 | $0.08 | $0.36 | — | $3.32 |
| 2017 | $2.74 | $0.51 | $0.07 | $0.39 | — | $4.25 |
| 2018 | $2.91 | $0.33 | $0.10 | $0.52 | — | $4.62 |
| 2019 | $2.49 | $0.27 | $0.15 | $0.01 | — | $4.98 |
| 2021 | $3.25 | −$0.32 | $0.30 | −$0.80 | — | $5.28 |
| 2022 | $5.34 | −$0.24 | $0.09 | −$0.74 | — | $5.01 |
| 2023 | $5.45 | $0.72 | $0.08 | $1.83 | — | $5.86 |
| 2024 | $2.50 | −$0.26 | $0.05 | $0.32 | — | $5.50 |
| 2025 | $1.57 | −$0.94 | $0.06 | −$0.72 | — | $4.84 |